 Electrophoretic Mobility Shift Assay
"Electrophoretic Mobility Shift Assay" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An electrophoretic technique for assaying the binding of one compound to another. Typically one compound is labeled to follow its mobility during electrophoresis. If the labeled compound is bound by the other compound, then the mobility of the labeled compound through the electrophoretic medium will be retarded.
| Descriptor ID |
D024202
|
| MeSH Number(s) |
E05.196.401.500
|
| Concept/Terms |
Electrophoretic Mobility Shift Assay- Electrophoretic Mobility Shift Assay
- EMSA Electrophoretic Technique
- EMSA Electrophoretic Techniques
- Electrophoretic Technique, EMSA
- Electrophoretic Techniques, EMSA
- Technique, EMSA Electrophoretic
- Techniques, EMSA Electrophoretic
- Band Shift Mobility Assay
- Mobility Shift Assay
- Assay, Mobility Shift
- Assays, Mobility Shift
- Mobility Shift Assays
- Bandshift Mobility Assay
- Assay, Bandshift Mobility
- Assays, Bandshift Mobility
- Bandshift Mobility Assays
- Mobility Assay, Bandshift
- Mobility Assays, Bandshift
Supershift Mobility Assay- Supershift Mobility Assay
- Assay, Supershift Mobility
- Assays, Supershift Mobility
- Mobility Assay, Supershift
- Mobility Assays, Supershift
- Supershift Mobility Assays
Gel Shift Analysis- Gel Shift Analysis
- Analyses, Gel Shift
- Analysis, Gel Shift
- Gel Shift Analyses
- Gelshift Analysis
- Gel Retardation Assay
- Assay, Gel Retardation
- Assays, Gel Retardation
- Gel Retardation Assays
|
Below are MeSH descriptors whose meaning is more general than "Electrophoretic Mobility Shift Assay".
Below are MeSH descriptors whose meaning is more specific than "Electrophoretic Mobility Shift Assay".
This graph shows the total number of publications written about "Electrophoretic Mobility Shift Assay" by people in UAMS Profiles by year, and whether "Electrophoretic Mobility Shift Assay" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2020 | 0 | 1 | 1 | | 2017 | 0 | 1 | 1 | | 2015 | 0 | 3 | 3 | | 2013 | 0 | 2 | 2 | | 2012 | 0 | 7 | 7 | | 2011 | 0 | 4 | 4 | | 2010 | 0 | 2 | 2 | | 2009 | 0 | 4 | 4 | | 2008 | 0 | 5 | 5 | | 2007 | 0 | 3 | 3 | | 2006 | 0 | 3 | 3 | | 2005 | 0 | 2 | 2 | | 2004 | 0 | 5 | 5 | | 2003 | 0 | 1 | 1 | | 2002 | 0 | 4 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Electrophoretic Mobility Shift Assay" by people in Profiles over the past ten years.
-
Lei MG, Lee CY. MgrA Activates Staphylococcal Capsule via SigA-Dependent Promoter. J Bacteriol. 2020 12 18; 203(2).
-
Parcon PA, Balasubramaniam M, Ayyadevara S, Jones RA, Liu L, Shmookler Reis RJ, Barger SW, Mrak RE, Griffin WST. Apolipoprotein E4 inhibits autophagy gene products through direct, specific binding to CLEAR motifs. Alzheimers Dement. 2018 02; 14(2):230-242.
-
Gupta RK, Luong TT, Lee CY. RNAIII of the Staphylococcus aureus agr system activates global regulator MgrA by stabilizing mRNA. Proc Natl Acad Sci U S A. 2015 Nov 10; 112(45):14036-41.
-
Burnett RM, Craven KE, Krishnamurthy P, Goswami CP, Badve S, Crooks P, Mathews WP, Bhat-Nakshatri P, Nakshatri H. Organ-specific adaptive signaling pathway activation in metastatic breast cancer cells. Oncotarget. 2015 May 20; 6(14):12682-96.
-
Yu D, Green B, Marrone A, Guo Y, Kadlubar S, Lin D, Fuscoe J, Pogribny I, Ning B. Suppression of CYP2C9 by microRNA hsa-miR-128-3p in human liver cells and association with hepatocellular carcinoma. Sci Rep. 2015 Feb 23; 5:8534.
-
Popuri V, Hsu J, Khadka P, Horvath K, Liu Y, Croteau DL, Bohr VA. Human RECQL1 participates in telomere maintenance. Nucleic Acids Res. 2014 May; 42(9):5671-88.
-
Pelham C, Jimenez T, Rodova M, Rudolph A, Chipps E, Islam MR. Regulation of HFE expression by poly(ADP-ribose) polymerase-1 (PARP1) through an inverted repeat DNA sequence in the distal promoter. Biochim Biophys Acta. 2013 Dec; 1829(12):1257-1265.
-
Radke JB, Lucas O, De Silva EK, Ma Y, Sullivan WJ, Weiss LM, Llinas M, White MW. ApiAP2 transcription factor restricts development of the Toxoplasma tissue cyst. Proc Natl Acad Sci U S A. 2013 Apr 23; 110(17):6871-6.
-
Cue D, Lei MG, Lee CY. Activation of sarX by Rbf is required for biofilm formation and icaADBC expression in Staphylococcus aureus. J Bacteriol. 2013 Apr; 195(7):1515-24.
-
Lin ZN, Lin YC, Zhang X, Kadlubar S, Tuo J, Green B, Deng H, Ning B. Differential promoter activities of functional haplotypes in the 5'-flanking region of human sulfotransferase 1A1. J Biochem Mol Toxicol. 2012 Oct; 26(10):422-8.
-
Ronis MJ, Baumgardner JN, Marecki JC, Hennings L, Wu X, Shankar K, Cleves MA, Gomez-Acevedo H, Badger TM. Dietary fat source alters hepatic gene expression profile and determines the type of liver pathology in rats overfed via total enteral nutrition. Physiol Genomics. 2012 Nov 15; 44(22):1073-89.
-
Hassed SJ, Wiley GB, Wang S, Lee JY, Li S, Xu W, Zhao ZJ, Mulvihill JJ, Robertson J, Warner J, Gaffney PM. RBPJ mutations identified in two families affected by Adams-Oliver syndrome. Am J Hum Genet. 2012 Aug 10; 91(2):391-5.
-
Burns SA, Lee Archer R, Chavis JA, Tull CA, Hensley LL, Drew PD. Mitoxantrone repression of astrocyte activation: relevance to multiple sclerosis. Brain Res. 2012 Sep 14; 1473:236-41.
-
Holcomb BK, Yip-Schneider MT, Waters JA, Beane JD, Crooks PA, Schmidt CM. Dimethylamino parthenolide enhances the inhibitory effects of gemcitabine in human pancreatic cancer cells. J Gastrointest Surg. 2012 Jul; 16(7):1333-40.
-
Moerman-Herzog AM, Barger SW. A polymorphism in the upstream regulatory region of the interleukin-1a gene confers differential binding by transcription factors of the AP-1 family. Life Sci. 2012 Jun 27; 90(25-26):975-9.
-
Morrison JM, Anderson KL, Beenken KE, Smeltzer MS, Dunman PM. The staphylococcal accessory regulator, SarA, is an RNA-binding protein that modulates the mRNA turnover properties of late-exponential and stationary phase Staphylococcus aureus cells. Front Cell Infect Microbiol. 2012; 2:26.
-
Zolova OE, Wight PA. YY1 negatively regulates mouse myelin proteolipid protein (Plp1) gene expression in oligodendroglial cells. ASN Neuro. 2011 Nov 03; 3(4).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|